AFT Pharma sets new $300M target after reaching $200M revenue for FY25
AFT Pharmaceuticals Ltd has unveiled its financial results for FY2025, announcing that it has reached a…
| Change | ||
| S&P/ASX Sm. Ords. | |||
| All Ordinaries | |||
| S&P/ASX 100 |